Clinical Trials Browser

Phase 4 × OTHER × pyrotinib × Clear all

NCT06217185 2024-02-28

The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

Phase 4 Recruiting

HER2-positive Breast Cancer